Keyphrases
Multiple Myeloma
100%
Relapsed or Refractory multiple Myeloma
27%
Myeloma
23%
Multiple Myeloma Patients
19%
Myeloma Cells
18%
Inducible Nitric Oxide Synthase
17%
Lenalidomide
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Melanoma Antigen Gene
11%
Bone Marrow
11%
Pomalidomide
10%
High Risk
10%
Overall Response Rate
9%
Newly Diagnosed multiple Myeloma
9%
Progression-free Survival
9%
Clinical Trials
9%
T Cells
8%
Plasma Cells
8%
Carfilzomib
8%
Cancer-testis Antigen
8%
Immunostimulatory DNA
8%
Phase II Study
8%
Macrophages
8%
Cyclophosphamide
8%
Refractory Myeloma
8%
Apoptosis
7%
Radiation Therapy
7%
Overall Survival
7%
Confidence Interval
7%
Bispecific Antibody
7%
Combination Therapy
7%
Tumor
6%
Lymphocyte Activity
6%
Mathematical Model
6%
Cyclin-dependent Kinase 4 (CDK4)
6%
Immune Response
6%
Relapsed or Refractory
6%
Smoldering multiple Myeloma
6%
Daratumumab
6%
Immunomodulatory Drugs (IMiDs)
5%
Immune Therapy
5%
Risk Stratification
5%
Intravenous Immunoglobulin (IVIg)
5%
Modern History
5%
DNA-based Vaccines
5%
Tumor Microenvironment
5%
Cyclin-dependent Kinase 6 (CDK6)
5%
Selinexor
5%
Melanoma Antigens
5%
COVID-19
5%
Immunology and Microbiology
Multiple Myeloma
87%
Dexamethasone
14%
T Cell
14%
Melanoma Antigen
14%
Immunity
13%
Myeloma Cell
12%
Progression Free Survival
11%
Immunotherapy
11%
Immunoglobulin Producing Cell
11%
Overall Survival
9%
Immune Response
9%
Cancer Testis Antigen
8%
Lenalidomide
8%
Cycline
8%
Pomalidomide
7%
Monoclonal Antibody
7%
B Cell Maturation Antigen
7%
Bispecific Antibody
7%
Cyclophosphamide
7%
Humoral Immunity
6%
Dynamics
6%
Daratumumab
6%
Immunology
6%
DNA Sequence
6%
Lymphocyte
5%
Smoldering Multiple Myeloma
5%
Neoantigen
5%
Tumor Antigen
5%
Adoptive Immunity
5%
Chimeric Antigen Receptor T-Cell Therapy
5%
CD8
5%
RNA Sequence
5%
CD4
5%
Monoclonal Immunoglobulinemia
5%
Medicine and Dentistry
Multiple Myeloma
79%
Myeloma
21%
Disease
12%
T Cell
11%
Clinical Trial
10%
Immunotherapy
9%
Progression Free Survival
9%
Immunoglobulin Producing Cell
9%
Melanoma Antigen
8%
Diseases
7%
Immune Response
7%
Overall Survival
6%
B Cell Maturation Antigen
6%
Dexamethasone
6%
Infection
6%
Smouldering Myeloma
6%
Cancer Testis Antigen
5%
Selinexor
5%
Immunoglobulin
5%
Tumor Microenvironment
5%
Chimeric Antigen Receptor T-Cell Immunotherapy
5%
Neoplasm
5%
Immunity
5%
Lenalidomide
5%
Monoclonal Antibody
5%